Cargando…
Biomarkers in Alzheimer’s disease: Evaluation of platelets, hemoglobin and vitamin B12
Currently, the most likely hypotheses as the cause of Alzheimer’s disease are deposition of amyloid beta peptide in the cerebral cortex and hyperphosphorylation of Tau protein. The diagnosis of Alzheimer’s disease is based on the exclusion of other diseases, behavioral assessments, and blood and ima...
Autores principales: | dos Santos, Gustavo Alves Andrade, Pardi, Paulo Celso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação de Neurologia Cognitiva e do
Comportamento
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077854/ https://www.ncbi.nlm.nih.gov/pubmed/32206196 http://dx.doi.org/10.1590/1980-57642020dn14-010006 |
Ejemplares similares
-
Influence of Rivastigmine transdermal on butyrylcholinesterase levels
in patients with Alzheimer's disease
por: dos Santos, Gustavo Alves Andrade, et al.
Publicado: (2011) -
Relationship between glycosylated hemoglobin and vitamin B12 deficiency anemia
por: Aydin, Bunyamin, et al.
Publicado: (2022) -
Vitamin B(12) Status and Optimal Range for Hemoglobin Formation in Elite Athletes
por: Krzywański, Jarosław, et al.
Publicado: (2020) -
Reversible Vitamin B12 Deficiency Presenting with Acute Dementia, Paraparesis, and Normal Hemoglobin
por: Almoallim, Hani, et al.
Publicado: (2016) -
Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
por: Lauer, Anna Andrea, et al.
Publicado: (2022)